Transdermal iontophoresis. Part II: Peptide and protein delivery

被引:28
作者
Pillai, O
Nair, V
Poduri, R
Panchagnula, R
机构
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Punjab 160062, India
[2] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Punjab 160062, India
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 1999年 / 21卷 / 03期
关键词
transdermal iontophoresis; peptides proteins; insulin; vasopressin; luteinizing hormone-releasing hormone; growth hormone releasing factor; thyrotropin releasing hormone;
D O I
10.1358/mf.1999.21.3.534833
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The advent of sophisticated biotechnological processes has generated an interest in peptide and protein pharmaceuticals. However the rapid developments in biotechnology are not matched by the developments in the delivery of these molecules. Presently, most of the peptides and proteins are delivered by parenteral route due to their poor oral bioavailability. The inherent discomforts associated with the parenteral therapy has prompted investigations into other nonparenteral routes and drug delivery techniques. Transdermal iontophoresis is one such technique showing good promise in the controlled and enhanced delivery of peptides and proteins. It offers noninvasive, continuous, pulsatile delivery as well as preprogrammed complex dosing regimens. Miniature battery powered and wearable patches for peptides and proteins are expected to be on the marker by the turn of this century. In continuation of our earlier review, this review explores the potential of transdermal iontophoresis for the delivery of peptides and proteins with the main focus on the suitability of the technique along with the factors to be considered in the design of this drug delivery system and its future prospects. (C) 1999 Prous Science. All rights reserved.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 119 条
[1]  
[Anonymous], 1991, PEPT PROTEIN DRUG DE
[2]  
Banerjee PS, 1991, PEPTIDE PROTEIN DRUG, P487
[3]  
BANGA AJ, 1992, PHARM RES, V10, P697
[4]   SYSTEMIC DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS [J].
BANGA, AK ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :15-50
[5]   TRANSDERMAL IONTOPHORETIC DELIVERY AND DEGRADATION OF VASOPRESSIN ACROSS HUMAN CADAVER SKIN [J].
BANGA, AK ;
KATAKAM, M ;
MITRA, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (02) :211-216
[6]   IONTOPHORETIC DELIVERY OF DRUGS - FUNDAMENTALS, DEVELOPMENTS AND BIOMEDICAL APPLICATIONS [J].
BANGA, AK ;
CHIEN, YW .
JOURNAL OF CONTROLLED RELEASE, 1988, 7 (01) :1-24
[7]   CHARACTERIZATION OF IN-VITRO TRANSDERMAL IONTOPHORETIC DELIVERY OF INSULIN [J].
BANGA, AK ;
CHIEN, YW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (16) :2069-2087
[8]   Iontophoresis of nafarelin across human skin in vitro [J].
Bayon, AMR ;
Guy, RH .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :798-800
[9]   Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin [J].
Bhatia, KS ;
Gao, S ;
Freeman, TP ;
Singh, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1011-1015
[10]   Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin [J].
Bhatia, KS ;
Singh, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (04) :462-469